摘要
重离子束肿瘤放疗较常规射线具有显著的放射物理和生物学优势。重离子束在直接杀伤肿瘤细胞的同时,可通过诱导肿瘤细胞免疫原性死亡、调节肿瘤表型、增强抗原提呈、改变肿瘤微环境等调节免疫应答,促进效应T细胞的启动和激活,减少免疫逃逸。本文将对重离子束肿瘤放疗的免疫调节作用及联合免疫检查点抑制剂治疗的相关分子机制进行综述。
Heavy ion radiation has significant radiological and biological advantages over conventional radiation.While directly killing tumor cells,heavy ion beam can reduce immune escape and promote the initiation and activation of effector T cells by inducing immunogenic death of tumor cells,regulating tumor phenotype,enhancing antigen formulation,and changing tumor microenvironment to regulate the immune response.This article will review the immunomodulatory effect of heavy ion beam and the molecular mechanisms associated with immune checkpoint inhibitor therapy.
作者
王江涛
关泉林
冉俊涛
Wang Jiangtao;Guan Quanlin;Ran Juntao(Department of Radiation Oncology,First Hospital of Lanzhou University,First Clinical Medical College of Lanzhou University,Lanzhou 730000,China;Department of Oncology Surgery,First Hospital of Lanzhou University,Lanzhou 730000,China)
出处
《中华放射医学与防护杂志》
CAS
CSCD
北大核心
2020年第11期888-892,共5页
Chinese Journal of Radiological Medicine and Protection
基金
甘肃省卫生行业科研管理项目(GSWSKY-2019-79)。
关键词
重离子
免疫调节
肿瘤微环境
免疫原性细胞死亡
Heavy ion
Immunomodulatory
Tumor microenvironment
Immunogenic cell death